{"id":"https://openalex.org/W4361936735","doi":"https://doi.org/10.1158/1078-0432.22475367","title":"Supplementary Figure S1-S15 from Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo\u2013Expanded Autologous NK Cells","display_name":"Supplementary Figure S1-S15 from Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo\u2013Expanded Autologous NK Cells","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361936735","doi":"https://doi.org/10.1158/1078-0432.22475367"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22475367","doi":"https://doi.org/10.1158/1078-0432.22475367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22475367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22475367","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100367914","display_name":"Yufeng Wang","orcid":"https://orcid.org/0009-0003-6701-6525","observed_orcids":["https://orcid.org/0009-0003-6701-6525","https://orcid.org/0000-0002-4576-1984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yufeng Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100320370","display_name":"Yibo Zhang","orcid":"https://orcid.org/0000-0002-0893-4962","observed_orcids":["https://orcid.org/0000-0002-0893-4962"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yibo Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008004469","display_name":"Tiffany L. Hughes","orcid":"https://orcid.org/0009-0007-4923-5280","observed_orcids":["https://orcid.org/0009-0007-4923-5280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiffany Hughes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100646259","display_name":"Jianying Zhang","orcid":"https://orcid.org/0000-0003-2938-9526","observed_orcids":["https://orcid.org/0000-0003-2938-9526"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianying Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049192022","display_name":"Michael A. Caligiuri","orcid":"https://orcid.org/0000-0002-4095-3020","observed_orcids":["https://orcid.org/0000-0002-4095-3020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Caligiuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112786802","display_name":"Don M. Benson","orcid":"https://orcid.org/0000-0001-8837-0548","observed_orcids":["https://orcid.org/0000-0001-8837-0548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Don M. Benson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100540392","display_name":"Jianhua Yu","orcid":"https://orcid.org/0000-0002-5553-2819","observed_orcids":["https://orcid.org/0000-0002-5553-2819","https://orcid.org/0009-0002-2039-9066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianhua Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.029600000008940697,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9589999914169312},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nk-cell-apoptosis","display_name":"NK cell apoptosis","score":0.6499999761581421},{"id":"https://openalex.org/keywords/ex-vivo-nk-cell-expansion","display_name":"ex vivo NK cell expansion","score":0.7839999794960022},{"id":"https://openalex.org/keywords/autologous-nk-cells","display_name":"autologous NK cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.8740000128746033},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8289999961853027},{"id":"https://openalex.org/keywords/stat1-signaling","display_name":"STAT1 signaling","score":0.8019999861717224},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9869999885559082},{"id":"https://openalex.org/keywords/nk-cell-subsets","display_name":"NK cell subsets","score":0.5799999833106995},{"id":"https://openalex.org/keywords/granzyme-b","display_name":"granzyme B","score":0.7059999704360962},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.6549999713897705},{"id":"https://openalex.org/keywords/anti-myeloma-therapy","display_name":"anti-myeloma therapy","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.8590514063835144},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.6058425307273865},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49310800433158875},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.47891223430633545},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.47353097796440125},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.42456087470054626},{"id":"https://openalex.org/C2781462264","wikidata":"https://www.wikidata.org/wiki/Q78482053","display_name":"CD16","level":5,"score":0.4169304370880127},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3773690164089203},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3660259246826172},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3598145842552185},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3293493986129761},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3029855191707611},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.27556112408638},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2530916929244995},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19994902610778809},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.19542786478996277},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.1445721983909607},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.12552586197853088},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.11574617028236389},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.11016348004341125},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.09773269295692444},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.061073362827301025},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22475367","doi":"https://doi.org/10.1158/1078-0432.22475367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22475367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22475367.v1","doi":"https://doi.org/10.1158/1078-0432.22475367.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22475367.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22475367","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1-S15_from_Fratricide_of_NK_Cells_in_Daratumumab_Therapy_for_Multiple_Myeloma_Overcome_by_i_Ex_Vivo_i_Expanded_Autologous_NK_Cells/22475367","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22475367","doi":"https://doi.org/10.1158/1078-0432.22475367","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22475367","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361953172","https://openalex.org/W2799762478","https://openalex.org/W2466761696","https://openalex.org/W3039959250","https://openalex.org/W3017317210","https://openalex.org/W3031449964","https://openalex.org/W2988236032","https://openalex.org/W4367693126","https://openalex.org/W3176072338","https://openalex.org/W2903132419"],"abstract_inverted_index":{"Supplementary":[0,12,25,45,60,82,91,102,118,150,167,183,205,217,240],"Figure":[1,13,26,46,61,83,92,103,119,151,168,184,206,218,241],"S1:":[2],"Dara":[3,28,48,85,163],"induces":[4],"IFN-gamma":[5],"expression":[6,17,55,171,187],"in":[7,56,64,71,190,210,234,236],"primary":[8,87,106,115],"human":[9],"NK":[10,68,88,107,116,130,157,181,194,203,212,220,252],"cells;":[11,59,117,182,204],"S2:":[14],"MM.1S":[15,33],"surface":[16,173],"of":[18,32,40,67,78,95,129,135,145,172,180,188,199,209,244],"CD38":[19],"was":[20],"assessed":[21],"by":[22],"flow":[23],"cytometry;":[24],"S3:":[27],"promotes":[29],"NK-mediated":[30],"ADCC":[31],"target":[34],"cells,":[35],"which":[36],"correlates":[37],"to":[38,50,122],"activation":[39],"STAT1":[41],"and":[42,75,99,141,159,177,192,201],"NF-kB":[43],"signaling;":[44],"S4:":[47],"fails":[49],"increase":[51],"apoptosis":[52],"or":[53,248,255],"IFNG":[54],"CD16(-)":[57],"NK-92":[58],"S5:":[62],"Reduction":[63],"relative":[65],"proportion":[66],"cells":[69,108,131,158,161,213,221,253],"occurs":[70],"both":[72],"peripheral":[73,133],"blood":[74,134],"bone":[76],"marrow":[77],"Dara-treated":[79,225],"MM":[80,148,160,226,233],"patients;":[81],"S6:":[84],"increases":[86],"cell":[89],"death;":[90],"S7:":[93],"Separation":[94],"daratumumab":[96],"into":[97],"F(ab')2":[98],"Fc":[100],"fragments;":[101],"S8:":[104],"CD38^\u00e2^'/low":[105,127,178,193],"show":[109,229],"lower":[110],"apoptotic":[111],"activity":[112],"than":[113],"CD38^+":[114,124,155,176,191],"S9:":[120],"Compared":[121],"their":[123,256],"counterparts,":[125],"the":[126],"subset":[128],"from":[132,224],"healthy":[136],"donors":[137],"are":[138],"more":[139],"proliferative":[140],"have":[142],"higher":[143],"levels":[144],"cytotoxicity":[146],"against":[147,232],"targets;":[149],"S10:":[152],"Competition":[153],"between":[154],"exp.":[156],"for":[162],"binding":[164],"during":[165],"co-culture;":[166],"S11:":[169],"Differential":[170,186],"receptors":[174],"within":[175,197],"subsets":[179,195],"S12:":[185],"GZMB":[189],"found":[196],"populations":[198],"CD56^bright":[200],"CD56^dim":[202],"S13:":[207],"Purity":[208],"vitro-expanded":[211],"at":[214],"day":[215],"7;":[216],"S14:":[219],"expanded":[222,251],"(eNK)":[223],"patient":[227],"PBMCs":[228],"anti-tumor":[230],"efficacy":[231],"an":[235],"vivo":[237],"mouse":[238],"model;":[239],"S15:":[242],"Treatment":[243],"MM-bearing":[245],"mice":[246],"with":[247],"without":[249],"Dara,":[250],"(eNK),":[254],"combination.":[257]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}